TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Borregaard Bioplant ApS
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
0
|
0 | |
| Earnings before taxes |
32
|
-65 | |
| Total assets |
1,333
|
1,305 | |
| Current assets |
1,265
|
1,242 | |
| Current liabilities |
525
|
553 | |
| Equity capital |
808
|
752 | |
| - share capital |
40
|
40 | |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
60.6%
|
57.6% | |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
241.0%
|
224.6% | |
| Return on equity (ROE) |
4.0%
|
-8.6% | |
| Change turnover |
0
|
0 | |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.